Trial intelligence / Profile preview

rhGH effect on circulating Klotho in children with isolated growth hormone deficiency

NL-OMON44245Active, not recruiting

Sponsor
Vrije University Medical Center
Start
May 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of somatropin in isolated growth hormone deficiency (IGHD), sponsored by Vrije University Medical Center. Primary endpoint: Absolute change in soluble Klotho levels. Started May 2015; status: active, not recruiting.

02

Drugs

somatropin
03

Conditions

isolated growth hormone deficiency (IGHD)

Beyond the preview

Go deeper on NL-OMON44245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call